Caplin Point Laboratories Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Caplin Point Laboratories (CAPLIPOINT (Bse Code: 524742)) Key Ratios
Caplin Point Laboratories Share Price Analysis Local DB
Caplin Point Laboratories share price is ₹2,720.50, day high (share price) is ₹2,735.80, day low (share price) is ₹2,650.00 and volume is 373,618. 52 Week high share price for Caplin Point Laboratories is ₹2,750.00 on 01 Sep 2026 and 52 week low share price for Caplin Point Laboratories is ₹1,500.30 on 30 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Caplin Point Laboratories share, 14 day period RSI (Relative Strength Index) is 64.2, 50 DMA (50 Displaced Moving Average) is 2,566.00 and 200 DMA (200 Displaced Moving Average) is 2,033.60.
Caplin Point Laboratories (CAPLIPOINT) Technical Analysis
Caplin Point Laboratories Technical Data and Analysis available in multiple timeframes.
Caplin Point Laboratories Oscillators Analysis
Caplin Point Laboratories Price Action
Caplin Point Laboratories Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 64.20 |
| Stoch %K (14, 3, 3) | 75.49 |
| CCI (20) | 220.99 |
| ADX (14) | 18.13 |
| Awesome Osc | 29.57 |
| Momentum (10) | 149.50 |
| MACD (12, 26, 9) | 22.93 |
| MACD Signal | 5.93 |
| Stoch RSI (14) | 83.70 |
| Williams %R (14) | -9.56 |
| Bull/Bear Power | 233.03 |
| Ultimate Osc | 57.12 |
| MFI (14) | 88.26 |
| ROC (21) | 5.78 |
| ROC (125) | 60.02 |
| ATR (14) | 92.32 |
Caplin Point Laboratories Moving Averages
| Ichimoku Base | 2,566.25 | Above Base |
| VWMA (20) | 2,631.14 | Above VWMA |
| HMA (9) | 2,661.21 | Above HMA |
Caplin Point Laboratories Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 64.2 indicates relatively strong momentum without being overbought.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- Price is near the upper Bollinger Band, which can indicate strong momentum or possible exhaustion.
Caplin Point Laboratories Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 3,042.80 | 3,068.50 | 2,776.93 | 2,896.40 |
| Resistance 2 | 2,896.40 | 2,909.25 | 2,755.02 | 2,805.10 |
| Resistance 1 | 2,803.80 | 2,829.50 | 2,733.11 | 2,748.70 |
| Pivot Point | 2,657.40 | 2,670.25 | 2,711.20 | 2,657.40 |
| Support 1 | 2,564.80 | 2,590.50 | 2,689.29 | 2,566.10 |
| Support 2 | 2,418.40 | 2,431.25 | 2,667.38 | 2,509.70 |
| Support 3 | 2,325.80 | 2,351.50 | 2,645.48 | 2,418.40 |
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Caplin Point Laboratories - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 70.57% | 70.57% | 70.57% | 70.57% |
| FII | 5.75% | 6.15% | 6.59% | 6.51% |
| DII (Other) | 0.47% | 0.12% | 0.09% | 0.31% |
| Retail & Others | 21.18% | 21.14% | 20.79% | 20.82% |
| Mutual Funds | 2.03% | 2.02% | 1.97% | 1.79% |
Caplin Point Laboratories - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 2,302.73 +13.22% | 802.79 +18.62% | 649.73 +20.08% |
| Mar 2025 | 2,033.90 +15.49% | 676.78 +19.91% | 541.09 +17.27% |
| Mar 2024 | 1,761.04 +15.65% | 564.43 +25.05% | 461.42 +22.4% |
| Mar 2023 | 1,522.71 | 451.35 | 376.99 |
Caplin Point Laboratories - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 29 May 2026 | ₹4 | View Details |
|
Announcement date
14 May 2026
Ex dividend date
29 May 2026
Record date
30 May 2026
Dividend type
Interim
Amount
4.0
Dividend %
200.0
Details
Rs.4.0000 per share(200%)Interim Dividend
|
|||
| Dividend | 12 Sep 2025 | ₹3 | View Details |
|
Announcement date
07 Aug 2025
Ex dividend date
12 Sep 2025
Record date
12 Sep 2025
Dividend type
Final
Amount
3.0
Dividend %
150.0
Details
Rs.3.0000 per share(150%)Final Dividend
|
|||
